Immunic ultimately hoping to "offer patients a new kind of treatment" for multiple sclerosis | News Direct

Immunic ultimately hoping to "offer patients a new kind of treatment" for multiple sclerosis

Immunic Inc
Digital Asset Direct by Immunic Inc
Download PDF Download multimedia

facebook icon linkedin icon twitter icon pinterest icon email icon London, UK | May 31, 2023 07:42 AM Eastern Daylight Time

Immunic Inc (NASDAQ:IMUX) president and CEO Dr Daniel Vitt joined Thomas Warner from Proactive on World Multiple Sclerosis day to talk about progress on the company's novel MS treatment. Dr Vitt explains what differentiates Immunic's molecule from other potential forms of treatment, saying that ultimately the company hopes to "offer patients a new kind of treatment."

 

Contact Details

 

Proactive United States

 

+1 347-449-0879

 

action@proactiveinvestors.com

DOWNLOAD

project media

Tags

ImmunicpharmabiotechMStreatmentProactiveinvestorstocks
News Direct Logo
Follow us on Facebook Follow us on LinkedIn
Get the latest from News Direct
Contact Us Pricing
Why News Direct
About us Features News Hub
Resources
Terms of Use Privacy Policy
newsdirect.com © 2024 News Direct Corp. All rights reserved. News Direct is a registered trademark.